Gotera N, Weilg P, Heleno C, Ferrari-Gabilondo N (2022) A case of Bullous Pemphigoid Associated with Nivolumab Therapy. Cureus 14(5):e24804. https://doi.org/10.7759/cureus.24804

Article  PubMed  PubMed Central  Google Scholar 

Lopez AT, Khanna T, Antonov N, Audrey-Bayan C, Geskin L (2018) A review of bullous pemphigoid associated with PD-1 and PD-L1 inhibitors. Int J Dermatol 57(6):664–669. https://doi.org/10.1111/ijd.13984

Article  CAS  PubMed  Google Scholar 

Schmidt E, della Torre R, Borradori L (2011) Clinical features and practical diagnosis of bullous pemphigoid. Dermatol Clin. 29(3):427–38, viii-ix. https://doi.org/10.1016/j.det.2011.03.010

Wongvibulsin S, Pahalyants V, Kalinich M et al (2022) Epidemiology and risk factors for the development of cutaneous toxicities in patients treated with immune-checkpoint inhibitors: a United States population-level analysis. J Am Acad Dermatol 86(3):563–572. https://doi.org/10.1016/j.jaad.2021.03.0947

Article  CAS  PubMed  Google Scholar 

Siegel J, Totonchy M, Damsky W, Berk-Krauss J, Castiglione F Jr, Sznol M et al (2018) Bullous disorders associated with anti-PD-1 and anti-PD-L1 therapy: a retrospective analysis evaluating the clinical and histopathologic features, frequency, and impact on cancer therapy. J Am Acad Dermatol 79(6):1081–1088. https://doi.org/10.1016/j.jaad.2018.07.008

Article  CAS  PubMed  Google Scholar 

Miyamoto D, Santi CG, Aoki V, Maruta CW (2019) Bullous pemphigoid. An Bras Dermatol 94(2):133–146. https://doi.org/10.1590/abd1806-4841.20199007

Article  PubMed  PubMed Central  Google Scholar 

Mazumder A, Darji K, Smith K, Guo M (2022) Two rare cases of bullous pemphigoid associated with immune checkpoint inhibitors. BMJ Case Rep 15(12):e253059. https://doi.org/10.1136/bcr-2022-253059

Article  PubMed  Google Scholar 

Hanley T, Papa S, Saha M (2018) Bullous pemphigoid associated with ipilimumab therapy for advanced metastatic melanoma. JRSM Open 9(10):2054270418793029. https://doi.org/10.1177/2054270418793029

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cuenca-Barrales C, Espadafor-López B, Martínez-López A, Cancela-Díez B, Ruiz-Villaverde R (2019) Bullous pemphigoid in a patient treated with nivolumab. Dermatol Ther 32(5):e13030. https://doi.org/10.1111/dth.13030

Article  PubMed  Google Scholar 

Hurkmans DP, Basak EA, van Dijk T, Mercieca D, Schreurs MWJ, Wijkhuijs AJM et al (2019) A prospective cohort study on the pharmacokinetics of nivolumab in metastatic non-small cell lung cancer, melanoma, and renal cell cancer patients. J Immunother Cancer 7(1):192. https://doi.org/10.1186/s40425-019-0669-y

Article  PubMed  PubMed Central  Google Scholar 

Delgado JC, Turbay D, Yunis EJ, Yunis JJ, Morton ED, Bhol K, Norman R, Alper CA, Good RA, Ahmed R (1996) A common major histocompatibility complex class II allele HLA-DQB1* 0301 is present in clinical variants of pemphigoid. Proc Natl Acad Sci U S A 93(16):8569–8571. https://doi.org/10.1073/pnas.93.16.8569

Article  CAS  PubMed  PubMed Central  Google Scholar 

Amber KT, Zikry J, Hertl M (2017) A multi-hit hypothesis of bullous pemphigoid and associated neurological disease: is HLA-DQB1*03:01, a potential link between immune privileged antigen exposure and epitope spreading? HLA 89(3):127–134. https://doi.org/10.1111/tan.12960

Article  CAS  PubMed  Google Scholar 

Di Lernia V, Casanova DM, Goldust M, Ricci C (2020) Pemphigus Vulgaris and Bullous Pemphigoid: update on diagnosis and treatment. Dermatol Pract Concept 10(3):e2020050. https://doi.org/10.5826/dpc.1003a50

Article  PubMed  PubMed Central  Google Scholar 

Moriuchi R, Nishie W, Ujiie H, Natsuga K, Shimizu H (2015) In vivo analysis of IgE autoantibodies in bullous pemphigoid: a study of 100 cases. J Dermatol Sci 78(1):21–25. https://doi.org/10.1016/j.jdermsci.2015.01.013

Article  CAS  PubMed  Google Scholar 

Boch K, Hammers CM, Goletz S, Kamaguchi M, Ludwig RJ, Schneider SW, Zillikens D, Hadaschik E, Schmidt E Immunoglobulin M pemphigoid. J Am Acad Dermatol. 202;85(6):1486–1492. https://doi.org/10.1016/j.jaad.2021.01.017

Schmidt E, Obe K, Bröcker EB, Zillikens D (2000) Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid. Arch Dermatol 136(2):174–178. https://doi.org/10.1001/archderm.136.2.174

Article  CAS  PubMed  Google Scholar 

Krenacs T, Kiszner G, Stelkovics E, Balla P, Teleki I, Nemeth I et al (2012) Collagen XVII is expressed in malignant but not in benign melanocytic tumors and it can mediate antibody induced melanoma apoptosis. Histochem Cell Biol 138(4):653–667. https://doi.org/10.1007/s00418-012-0981-9

Article  CAS  PubMed  Google Scholar 

Ellis SR, Vierra AT, Millsop JW, Lacouture ME, Kiuru M (2020) Dermatologic toxicities to immune checkpoint inhibitor therapy: a review of histopathologic features. J Am Acad Dermatol 83(4):1130–1143. https://doi.org/10.1016/j.jaad.2020.04.105

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wojnarowska F, Kirtschig G, Highet AS, Venning VA, Khumalo NP (2002) British Association of Dermatologists. Guidelines for the management of bullous pemphigoid. Br J Dermatol 147(2):214–221. https://doi.org/10.1046/j.1365-2133.2002.04835.x

Article  CAS  PubMed  Google Scholar 

Kárpáti H, Marinovic S, Mimouni B, Uzun D, Yayli S, Hertl S, Borradori M (2015) Management of bullous pemphigoid: the european Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology. Br J Dermatol 172(4):867–877. https://doi.org/10.1111/bjd.13717

Article  PubMed  Google Scholar 

Munera-Campos M, Plana-Pla A, Rivera N, Boada A, Ferrándiz C (2020) Nivolumab-Induced Bullous Pemphigoid Managed without Drug Withdrawal. Indian J Dermatol 65(3):214–216. https://doi.org/10.4103/ijd.IJD_321_18

Article  PubMed  PubMed Central  Google Scholar 

Povilaityte E, Gellrich FF, Beissert S, Abraham S, Meier F, Günther C (2021) Treatment-resistant bullous pemphigoid developing during therapy with immune checkpoint inhibitors. J Eur Acad Dermatol Venereol 35(9):e591–e593. https://doi.org/10.1111/jdv.17321

Article  CAS  PubMed  Google Scholar